Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-31 @ 4:04 AM
Study NCT ID:
NCT07433192
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-25
First Post:
2026-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.
Sponsor:
Servier Russia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-19
First Submit QC Date:
None
Study First Post Date:
2026-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-19
Last Update Post Date:
2026-02-25
Last Update Post Date Type:
ACTUAL